BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 18758159)

  • 1. Replication timing of two human common fragile sites: FRA1H and FRA2G.
    Pelliccia F; Bosco N; Curatolo A; Rocchi A
    Cytogenet Genome Res; 2008; 121(3-4):196-200. PubMed ID: 18758159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stably transfected common fragile site sequences exhibit instability at ectopic sites.
    Ragland RL; Glynn MW; Arlt MF; Glover TW
    Genes Chromosomes Cancer; 2008 Oct; 47(10):860-72. PubMed ID: 18615677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of the human common fragile site FRA1H.
    Curatolo A; Limongi ZM; Pelliccia F; Rocchi A
    Genes Chromosomes Cancer; 2007 May; 46(5):487-93. PubMed ID: 17311248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of late/slow replication of the FRA16D in common fragile site induction.
    Palakodeti A; Han Y; Jiang Y; Le Beau MM
    Genes Chromosomes Cancer; 2004 Jan; 39(1):71-6. PubMed ID: 14603443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common fragile sites are conserved features of human and mouse chromosomes and relate to large active genes.
    Helmrich A; Stout-Weider K; Hermann K; Schrock E; Heiden T
    Genome Res; 2006 Oct; 16(10):1222-30. PubMed ID: 16954539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired Replication Timing Promotes Tissue-Specific Expression of Common Fragile Sites.
    Maccaroni K; Balzano E; Mirimao F; Giunta S; Pelliccia F
    Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32204553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional profiling of genes at the human common fragile site FRA1H in tumor-derived cell lines.
    Pelliccia F; Curatolo A; Limongi ZM; Bosco N; Rocchi A
    Cancer Genet Cytogenet; 2007 Oct; 178(2):144-50. PubMed ID: 17954271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogene-induced replication stress preferentially targets common fragile sites in preneoplastic lesions. A genome-wide study.
    Tsantoulis PK; Kotsinas A; Sfikakis PP; Evangelou K; Sideridou M; Levy B; Mo L; Kittas C; Wu XR; Papavassiliou AG; Gorgoulis VG
    Oncogene; 2008 May; 27(23):3256-64. PubMed ID: 18084328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replication of a common fragile site, FRA3B, occurs late in S phase and is delayed further upon induction: implications for the mechanism of fragile site induction.
    Le Beau MM; Rassool FV; Neilly ME; Espinosa R; Glover TW; Smith DI; McKeithan TW
    Hum Mol Genet; 1998 Apr; 7(4):755-61. PubMed ID: 9499431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Claspin inhibition leads to fragile site expression.
    Focarelli ML; Soza S; Mannini L; Paulis M; Montecucco A; Musio A
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1083-90. PubMed ID: 19760606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel aphidicolin-inducible common fragile site FRA9G maps to 9p22.2, within the C9orf39 gene.
    SawiƄska M; Schmitt JG; Sagulenko E; Westermann F; Schwab M; Savelyeva L
    Genes Chromosomes Cancer; 2007 Nov; 46(11):991-9. PubMed ID: 17668870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-copy repeats on chromosome 22q11.2 show replication timing switches, DNA flexibility peaks and stress inducible asynchrony, sharing instability features with fragile sites.
    Puliti A; Rizzato C; Conti V; Bedini A; Gimelli G; Barale R; Sbrana I
    Mutat Res; 2010 Apr; 686(1-2):74-83. PubMed ID: 20138061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of FRA7B, a human common fragile site mapped at the 7p chromosome terminal region.
    Bosco N; Pelliccia F; Rocchi A
    Cancer Genet Cytogenet; 2010 Oct; 202(1):47-52. PubMed ID: 20804921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of DNA replication by fluorescence in situ hybridization.
    Boggs BA; Chinault AC
    Methods; 1997 Nov; 13(3):259-70. PubMed ID: 9441852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common fragile sites: mechanisms of instability revisited.
    Debatisse M; Le Tallec B; Letessier A; Dutrillaux B; Brison O
    Trends Genet; 2012 Jan; 28(1):22-32. PubMed ID: 22094264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The characterization of the common fragile site FRA16D and its involvement in multiple myeloma translocations.
    Krummel KA; Roberts LR; Kawakami M; Glover TW; Smith DI
    Genomics; 2000 Oct; 69(1):37-46. PubMed ID: 11013073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The common fragile site FRA16D and its associated gene WWOX are highly conserved in the mouse at Fra8E1.
    Krummel KA; Denison SR; Calhoun E; Phillips LA; Smith DI
    Genes Chromosomes Cancer; 2002 Jun; 34(2):154-67. PubMed ID: 11979549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breakages at common fragile sites set boundaries of amplified regions in two leukemia cell lines K562 - Molecular characterization of FRA2H and localization of a new CFS FRA2S.
    Pelliccia F; Bosco N; Rocchi A
    Cancer Lett; 2010 Dec; 299(1):37-44. PubMed ID: 20851513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the human/mouse syntenic common fragile site FRA7K/Fra12C1--relation of FRA7K and other human common fragile sites on chromosome 7 to evolutionary breakpoints.
    Helmrich A; Stout-Weider K; Matthaei A; Hermann K; Heiden T; Schrock E
    Int J Cancer; 2007 Jan; 120(1):48-54. PubMed ID: 17039484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biallelic deletion and loss of expression analysis of genes at FRA2G common fragile site in tumor-derived cell lines.
    Limongi ZM; Curatolo A; Pelliccia F; Rocchi A
    Cancer Genet Cytogenet; 2005 Sep; 161(2):181-6. PubMed ID: 16102592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.